MX342850B - Proceso para la preparacion de triazolonas quirales. - Google Patents

Proceso para la preparacion de triazolonas quirales.

Info

Publication number
MX342850B
MX342850B MX2012013334A MX2012013334A MX342850B MX 342850 B MX342850 B MX 342850B MX 2012013334 A MX2012013334 A MX 2012013334A MX 2012013334 A MX2012013334 A MX 2012013334A MX 342850 B MX342850 B MX 342850B
Authority
MX
Mexico
Prior art keywords
formula
preparation
chiral
triazolones
chiral compound
Prior art date
Application number
MX2012013334A
Other languages
English (en)
Other versions
MX2012013334A (es
Inventor
Sturm Hubert
Albert Martin
Oberhuber Michael
Salchenegger Jörg
De Souza Dominic
Wilhelm Thorsten
Langner Martin
Spitzenstätter Hans-Peter
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2012013334A publication Critical patent/MX2012013334A/es
Publication of MX342850B publication Critical patent/MX342850B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de un compuesto quiral, en particular posaconazol, en donde el proceso comprende mezclar y hacer reaccionar los compuestos de la fórmula (I) Y3-NH2 de la fórmula (IIa) O=C=N-Y0 y/o de la fórmula (lIb) y de la fórmula (III), en un disolvente, en cualquier orden, para obtener una mezcla de reacción que contiene un compuesto quiral de la fórmula (IV) y/o de la fórmula (V).
MX2012013334A 2010-05-19 2011-05-18 Proceso para la preparacion de triazolonas quirales. MX342850B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10163213 2010-05-19
PCT/EP2011/058033 WO2011144653A1 (en) 2010-05-19 2011-05-18 Process for the preparation of chiral triazolones

Publications (2)

Publication Number Publication Date
MX2012013334A MX2012013334A (es) 2013-02-01
MX342850B true MX342850B (es) 2016-10-14

Family

ID=42697228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013334A MX342850B (es) 2010-05-19 2011-05-18 Proceso para la preparacion de triazolonas quirales.

Country Status (10)

Country Link
US (1) US9040539B2 (es)
EP (1) EP2571871B1 (es)
JP (1) JP6013326B2 (es)
CN (1) CN102906087B (es)
AU (1) AU2011254654B2 (es)
BR (1) BR112012029227B1 (es)
CA (1) CA2798002C (es)
MX (1) MX342850B (es)
RU (1) RU2585760C2 (es)
WO (1) WO2011144653A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
US20150164890A1 (en) 2012-06-14 2015-06-18 Sandoz Ag Pharmaceutical compositions comprising crystalline posaconazole
CN103086885B (zh) * 2013-02-28 2015-04-01 天津大学仁爱学院 一种泊沙康唑中间体的制备方法
EP2789610A1 (en) 2013-04-10 2014-10-15 Sandoz Ag Purification of Posaconazole Intermediates
CA2919290A1 (en) 2013-07-25 2015-01-29 Sandoz Ag Improved process for the preparation of crystalline form iv of posaconazole
EP3060559A4 (en) * 2013-10-22 2017-05-24 MSN Laboratories Private Limited Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonate
CN105622590B (zh) * 2014-10-30 2019-08-20 上海美悦生物科技发展有限公司 一种泊沙康唑的晶型vi及其制备方法
CN105777720B (zh) * 2014-12-26 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种泊沙康唑中间体的新晶型及制备方法
WO2017093491A1 (en) * 2015-12-04 2017-06-08 Pulmocide Limited Antimycotic triazole compound
CN105622413B (zh) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 2‑[2‑(2，4‑二氟苯基)烯丙基]‑1，3‑丙二酸二乙酯的合成方法
CN105622412B (zh) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 一种合成2‑[2‑(2，4‑二氟苯基)烯丙基]‑1，3‑丙二酸二乙酯的方法
CN105601469B (zh) * 2016-01-14 2017-07-25 宁波新凯生物科技有限公司 1‑(1‑氯甲基乙烯基)‑2，4‑二氟苯的合成方法
CN105753693B (zh) * 2016-03-30 2017-12-22 宁波新凯生物科技有限公司 2‑甲基丙酸‑[(2s)‑4‑(2，4‑二氟苯基)‑2‑羟甲基‑4‑戊烯‑1‑基]酯的合成方法
CN105755060B (zh) * 2016-03-30 2019-01-04 浙江大学宁波理工学院 一种2-甲基丙酸-[(2s)-4-(2，4-二氟苯基)-2-羟甲基-4-戊烯-1-基]酯的合成方法
CN105732311B (zh) * 2016-03-30 2017-12-22 宁波新凯生物科技有限公司 一种合成2‑[2‑(2，4‑二氟苯基)‑2‑丙烯‑1‑基]‑1，3‑丙二醇的方法
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2，4-二氟苯基)-2-丙烯-1-基]-1，3-丙二醇的合成方法
CN105753692B (zh) * 2016-03-30 2017-12-26 宁波新凯生物科技有限公司 一种合成2‑甲基丙酸‑[(2s)‑4‑（2，4‑二氟苯基）‑2‑羟甲基‑4‑戊烯‑1‑基]酯的方法
CN106040301B (zh) * 2016-06-12 2019-01-15 南京大学 一种用于合成甲基异丁基酮的高分子金属络合催化剂
CN106397417A (zh) * 2016-08-30 2017-02-15 甘肃皓天化学科技有限公司 用于制备泊沙康唑的中间体的制备方法
CN106632284A (zh) * 2016-09-04 2017-05-10 甘肃皓天化学科技有限公司 泊沙康唑的制备方法
CN112898279A (zh) * 2019-11-19 2021-06-04 爱之源生物科技有限公司 一种高纯度的泊沙康唑的精制方法
CN115448911B (zh) * 2022-10-12 2024-08-16 成都海博为药业有限公司 一种泊沙康唑中间体的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5403937A (en) 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5349099A (en) 1993-12-13 1994-09-20 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5714490A (en) * 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
ZA9410142B (en) * 1993-12-21 1996-05-02 Schering Corp Tetrahydrofuran antifungals
US5693626A (en) * 1993-12-21 1997-12-02 Schering Corporation Tetrahydrofuran antifungals
US5710154A (en) * 1993-12-21 1998-01-20 Schering Corporation Tetrahydrofuran antifungals
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
WO1996013499A1 (en) * 1994-10-27 1996-05-09 Janssen Pharmaceutica N.V. Apolipoprotein-b synthesis inhibitors
US5616777A (en) 1995-04-19 1997-04-01 Schering Corporation Chiral hydrazine derivatives
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
MX9701229A (es) 1995-06-02 1997-05-31 Schering Corp Antifungicos de tetrahidrofurano.
AU6257596A (en) * 1995-06-19 1997-01-15 Schering Corporation Hydroxyalkyl-substituted triazolones antifungals
WO1997000255A1 (en) 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
CA2240408C (en) 1995-12-20 2007-04-24 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
BR9612046A (pt) 1995-12-20 1999-02-09 Schering Corp Processo para a preparação de hidrazidas
DE59702207D1 (de) 1996-03-08 2000-09-21 Octapharma Ag Lachen Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
EP0938487A2 (en) * 1996-11-12 1999-09-01 Sepracor, Inc. 2$i(R),4$i(S),$i(R),$i(S)- AND 2$i(S),4$i(R),$i(R),$i(S)-HYDROXYITRACONAZOLE- AND HYDROXYSAPERCONAZOLE DERIVATIVES
HU227744B1 (en) * 1997-02-11 2012-02-28 Janssen Pharmaceutica Nv Amino acid ester containing azole antifungals, process for their preparation, pharmaceuticals containing the same and intermediates
JP3473949B2 (ja) * 1997-09-25 2003-12-08 シェーリング コーポレイション 対応する抗真菌剤のためのプロドラッグとしてのテトラヒドロフランリン酸エステルおよびヒドロキシエステル
JP2001519346A (ja) * 1997-10-07 2001-10-23 シェーリング コーポレイション 抗真菌性結晶性多形物
US6713481B1 (en) 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
US6355801B1 (en) 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
AU1465301A (en) 1999-11-08 2001-06-06 Schering Corporation Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
FR2807434B1 (fr) * 2000-04-05 2002-10-18 Hoechst Marion Roussel Inc Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides
BR0208626A (pt) 2001-04-03 2004-03-09 Schering Corp Composição antifúngica com biodisponibilidade intensificada
BRPI0508514A (pt) * 2004-03-10 2007-08-14 Janssen Pharmaceutica Nv aril piperidinas ou piperazinas substituìdas por heterociclos de 5-membros inibidoras de mtp
EP1761247A1 (en) 2004-05-28 2007-03-14 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
CN101006074B (zh) 2004-07-01 2012-02-15 欧科生医股份有限公司 作为nk1拮抗剂的哌啶衍生物
MX2008015275A (es) 2006-05-30 2009-02-06 Elan Pharma Int Ltd Formulaciones de posaconazol en nanoparticulas.
WO2009129297A1 (en) 2008-04-15 2009-10-22 Schering Corporation Semi-solid oral pharmaceutical compositions
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
CN101323600B (zh) * 2008-07-25 2010-08-25 西南大学 具有抗微生物活性的三唑酮、三唑醇类化合物及其盐、合成方法及用途
US20100143455A1 (en) * 2008-09-08 2010-06-10 Nian Wu Triazole antifungal agents
BRPI0924302A2 (pt) 2009-02-05 2019-09-24 Targeted Delivery Tech Limited métodos de reduzir a proliferação e a viabilidade de agentes microbianos
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
US20150164890A1 (en) 2012-06-14 2015-06-18 Sandoz Ag Pharmaceutical compositions comprising crystalline posaconazole

Also Published As

Publication number Publication date
RU2585760C2 (ru) 2016-06-10
CA2798002A1 (en) 2011-11-24
EP2571871A1 (en) 2013-03-27
US9040539B2 (en) 2015-05-26
WO2011144653A1 (en) 2011-11-24
RU2012154811A (ru) 2014-06-27
CA2798002C (en) 2019-12-03
CN102906087A (zh) 2013-01-30
AU2011254654B2 (en) 2016-01-07
MX2012013334A (es) 2013-02-01
JP2013527182A (ja) 2013-06-27
EP2571871B1 (en) 2017-06-21
BR112012029227A2 (pt) 2016-11-29
CN102906087B (zh) 2016-03-23
AU2011254654A1 (en) 2012-12-20
BR112012029227B1 (pt) 2020-01-07
JP6013326B2 (ja) 2016-10-25
US20130210833A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
MX342850B (es) Proceso para la preparacion de triazolonas quirales.
MX2013005008A (es) Derivados de carboxamida y urea heteroaromaticos sustituidos como ligandos del receptor vanilloide.
MX347841B (es) Procedimiento para preparar derivados de antranilamida sustituidos con tetrazoles y polimorfos cristalinos novedosos de estos derivados.
MX2010009860A (es) Sintesis total de salinosporamida a y sus analogos.
GEP20217235B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
UA93883C2 (ru) Производные пиразина, полезные kak антагонисты аденозинового рецептора
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
NZ595591A (en) Processes for the preparation of morphinane and morphinone compounds
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
EA201391522A1 (ru) Способ получения соединений для применения в качестве ингибиторов sglt2
TW200732323A (en) Organic compounds
TN2012000506A1 (en) Process for the preparation of pleuromutilins
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
PH12013501859A1 (en) Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
MX2009011149A (es) Ligandos de receptor de vainilloide novedosos y el uso de los mismos para la produccion de sustancias farmaceuticas.
MX337804B (es) Proceso para la preparacion de hidrazinas quirales.
MY155300A (en) Preparation of saturated imidazolinium salts and related compounds
MX2009011207A (es) Eteres de amidas de acido naftalen-carboxilico como cura para el cancer.
GB201104203D0 (en) Chemical process
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
MY168411A (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
MX349740B (es) Proceso para la preparacion de fenilpropanonas sustituidas.
IN2012DN01245A (es)
WO2007128601A3 (en) Method for the preparation of a compound of the general formula r1-r1 and/or r1-r2 using homo and hetero coupling reactions

Legal Events

Date Code Title Description
FG Grant or registration